Z-2150-2019 Class II Terminated

Recalled by Randox Laboratories, Limited — Crumlin, N/A

FDA device recall Z-2150-2019 was initiated by Randox Laboratories, Limited on Jun 11, 2019 and is designated Class II. Reason for recall: The RX Series control target and range value for ALT (Tris buffer without P5P 37C), Bicarbonate and Gamma-GT has been incorrectly assigned in specific lots of the Human Assayed Multi-Sera Controls. The recall status is terminated (terminated May 15, 2020). Affected quantity: 149 (US).

Recall details

Product Type
Devices
Report Date
Aug 14, 2019
Initiation Date
Jun 11, 2019
Termination Date
May 15, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
149 (US)

Product description

Human Assayed Multi-Sera Level 2, Model NO. HN1530 Product Usage: This product is intended for in vitro diagnostic use, in the quality control of diagnostic assays. The Human Assayed Multi-sera is for the control of accuracy.

Reason for recall

The RX Series control target and range value for ALT (Tris buffer without P5P 37C), Bicarbonate and Gamma-GT has been incorrectly assigned in specific lots of the Human Assayed Multi-Sera Controls.

Distribution pattern

US Nationwide Distribution - AZ CA CT FL GA IL KY LA MA MD MI MN MO NJ NY OH OK OR PA TX UT VA WA WI WV and PR. Worldwide foreign distribution.

Code information

1306UN, 1308UN, 1309UN

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2150-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2150-2019. Report a data issue: hello@regdatalab.com.